The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Columbia U receives $16.9M award to study origin and health effects of arsenic in ground water

Researchers at Columbia University's Mailman School of Public Health, Lamont-Doherty Earth Observatory and Center for International Earth Science Information Network announced that they have been awarded a five-year, $16.9 million grant renewal from the National Institute of Environmental Health Sciences (NIEHS) Superfund Basic Research Program (SBRP). The grant will fund ongoing investigations into the health effects and geochemistry of arsenic and manganese exposure, particularly in groundwater of New England and South Asia.

Building upon Columbia University's SBRP research progress over the past six years in conjunction with a previous, $11 million award, the highly competitive grant renewal will enable this multi-disciplinary team of scientists to conduct research concerning anthropogenic and naturally occurring sources of human exposure to arsenic and manganese in New York, New Jersey, New Hampshire, and Maine. The award also allows for a continuation of the group's landmark work in Bangladesh, where tens of millions of people have been chronically exposed to naturally occurring arsenic in drinking water. Although arsenic is an environmental carcinogen that affects millions of people worldwide, at high levels such as those found in Bangladesh it is also associated with a constellation of other adverse health effects, including diseases of the cardiovascular, pulmonary, endocrine, and nervous systems.

According to the team's researchers, arsenic contamination of groundwater and soils is associated with serious and widespread public health, mitigation, and environmental policy problems. "Arsenic contamination of groundwater has been documented in nearly 20 countries, including the U.S. as the result of either natural geologic processes or from mining, industrial and agricultural activities," said Joseph Graziano, professor of Environmental Health Sciences and director of the Columbia Superfund program. "Because exposure to arsenic in drinking w
'"/>

Contact: stephanie berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
2-Aug-2006


Page: 1 2 3

Related medicine news :

1. Columbia dentists to improve oral health in sub-Saharan Africa
2. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
3. Columbia study examines ADHDs role in smoking
4. Columbia scientists present research findings at AHA Scientific Sessions
5. Columbia pediatricians, Anne Gershon and Richard Polin, awarded top honors
6. Columbia researchers restore memory lost in mice with Alzheimers
7. Research at University of British Columbia receives historical recognition
8. Columbia receives up to $15 million from Spinal Muscular Atrophy Foundation
9. Columbia study suggests benefits of Zyflamend in the early treatment of prostate cancer
10. Columbia study shows how doctors may manage blood glucose levels during heart surgery
11. Columbia study shows elderly with diabetes at increased risk for falling

Post Your Comments:
(Date:11/8/2009)...ire/ -- Pharmaceutical Research and Manufacturers ...on released the following statement regarding the ...pointed, but not surprised by today,s vote -- an u...ans as well as nearly half of the members of the U... bill. ,, "While well intentioned, the bill -- ...
(Date:11/8/2009)...Care Reform Bill ,, Critical legislation woul...ericans ,, BALTIMORE, Nov. 7 /PRNewswire-USNew...se of Representatives passed critical health care ...for seniors and end discrimination by insurance co...ffordable health coverage. ,, The Affordable He...
(Date:11/7/2009).../ -- The American Medical Association (AMA) proudl...Family Violence Prevention Fund, with the Citation...l policy-making meeting. The Citation for Disting...of Delegates bestows on a non-physician. ,, (...209/AMALOGO ) ,, "Ms. James has worked selfle...
(Date:11/7/2009)...sponsibility to vigorously oppose abortion in heal...HINGTON, Nov. 7 Amer...e following statement on the news that Cardinal Ju...fordable Health Care for America Act (H.R. 3962), ...r abortion is voted upon. ,, "Our Catholic bis...
(Date:11/7/2009)...rebel, expert says , , SATURDAY, Nov. 7 (H...badly if their parents expect them to, a new U.S. ...imply being realistic might actually contribute to...psychology professor at Wake Forest University and... release. "Negative expectations on the part of bo...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
(Date:11/6/2009)...wire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulleti...lanta-based, biopharmaceutical company developing ... Immunodeficiency Virus) and other infectious agen...al results and provided an operational update. ,...utive Officer commented, "We are pleased with our ...
(Date:11/6/2009)...PRNewswire/ -- , - Trial Will Compare NXL...tment of Multi-Resistant Staphylococcus Aureus (MR...armaceutical company focused on the discovery and,...ome the significant global,problem of microbial re...ral,antibacterial NXL103 (flopristin/linopristin),...
(Date:11/5/2009)... Helix BioPharma Corp. (...at its Phase II trial of Topical Interferon Alpha-...s completed patient enrollment, with the required ... The double-blind and placebo-controlled Phase II ...nd Sweden. Patients participating in the trial se...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 1Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 2Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 3Burner Balm Gets International Attention 52477 1Burner Balm Gets International Attention 52477 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 1Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 3
Other News:
...An inhaled anti-rejection drug can dramatically im...to a study conducted at the University of Pittsbur... at the University of Maryland in Baltimore. The r...2, 2006 edition of the New England Journal of Medi...
...Eating a very low-calorie yet nutritionally balanc...ction in members of an organization called the Cal...ton University School of Medicine in St. Louis fou... much younger people. The researchers report their...
The human body contains many metals, from the iron in hemoglobin to the calcium in bones. Other metals, usually in trace amounts, participate in many metabolic and degenerative processes. The recent i
...This month, the medical humanitarian organisation,...n initiative to help vulnerable people to access h...n why such a scheme is needed, while an editorial ...owards marginalised people.......Providing health ...
health news:Study shows inhaled medicine improves survival for lung transplant patients 2health news:Study shows inhaled medicine improves survival for lung transplant patients 3health news:Study shows inhaled medicine improves survival for lung transplant patients 4health news:Caloric restriction appears to prevent primary aging in the heart 2health news:Caloric restriction appears to prevent primary aging in the heart 3health news:Caloric restriction appears to prevent primary aging in the heart 4
...unces nationwide initiative to boost awareness of....arcolepsy Network announced today that it.is joini..."Wake Up to.Narcolepsy," an educational initiative...narcolepsy and its treatment. An estimated 125,00...
...em, N.C. -- Researchers at Wake Forest University ...to report the successful use of.magnetic resonance...n blood.vessels leading to the heart. This is the ...nd determine if they require treatment... M...
...nts may face an increased risk of depression as a ...pplies of estrogen, according to the.results of a ...pital, Boston. .."Dysphoria, insomnia, and hot fla...ancer treatment induced estrogen deficiency," says...
... 1999 -- America's growing use of depression-treat...epressants the biggest contributors to a.record-se...nt last year,.according to a study by the country'...press Scripts, Inc. ..Not everyone was hit by the...
health news:Narcolepsy network issues national 'wake up' call 2health news:Narcolepsy network issues national 'wake up' call 3health news:Wake Forest researchers develop new technique to diagnose narrowed heart,arteries 2health news:Breast cancer patients face increased depression 2health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 2health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 3health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 4